supported by The National Natural Science Foundation of China(No.81770154,81970194,and 82170176);the National Key Research and Development Program of China(No.2022YFC2705003);Guangzhou Medical University Discipline Construction Funds(Basic Medicine)(China)(No.JCXKJS2022A05);Guangzhou Key Discipline of Medicine(Geriatric Medicine)(China)(No.ZDXK202103).
Chronic myelogenous leukemia(CML)is a malignancy from bone marrow myeloid stem cells mainly driven by the fusion gene BCR-ABL.In addition to BCR-ABL,other genes including RNF6 are also dysregulated in CML cells.1 RNF6...
Objective: to treat leukemia patients with chemotherapy with leukemia reduction symptoms with left supplemented myeloid blood soup and analyze its effect. Methods: a total of 82 patients were selected by double-blind ...
Clinical trials have demonstrated that some patients with chronic myeloid leukemia(CML)treated for several years with tyrosine kinase inhibitors(TKIs)who have maintained a molecular response can successfully discontin...
Objective: This study aimed to report the case of a female patient with chronic myeloid leukemia affected by cryptococcal meningitis. Case report: ML, white, 48 years old, female sex, previously diagnosed with chronic...
Objective:To study the correlation of Aurora family and TRPV family gene expression in acute myelogenous leukemia with disease progression.Methods: Patients who were diagnosed with acute myelogenous leukemia in Kashga...
To the Editor: Allogeneic hematopoietic siena cell transplantation (aLIo-HSCT) is a curative therapy for patients with acute myelogenous letikemia (A M L) due to the intensive conditioning chemoradiotherapy and t...
Objective To analyze the difference of efficacy and prognostic factors between MA and CAG induction chemotherapy in elderly acute myelogenous leukemia(AML)patients.Methods From April 2009 to September 2015,103 consecu...
Myeloid sarcoma, also known as granulocytic sarcoma or chloroma is an unusual accumulation of malignant myeloid precursor cells in an extramedullary site, which disrupts the normal architecture of the involved tissue....